A Single Shot of HPV can have about 4 years of Efficacy

Recent studies have proved that a single shot of the HPV vaccine can have an effect that lasts about 4 years; however, some women may not be able to get hold of this vaccine.

In the latest publication, it has been discovered that one shot of HPV (human papillomavirus) vaccine can trigger the buildup of antibodies that are strong enough to withstand the virus for around 4 years.

Knowing that this virus is responsible for 70% of all cervical cancer cases in women, the good news is that a vaccine shot is enough protection for women.

The HPV vaccine in the UK is usually administered in 3 doses and available for sale under Gardasil and Cervarix's brand names. The CDC's report shows an estimated 53.8 percent of female children aged between 13 to 17 years started receiving the HPV vaccine in 2012, and just a third of this number were given the 3 doses. Again, the CDC has reported that human papillomavirus is a very common STI.

Making the vaccine schedule simple

To know how effective Cervarix is, a phase 3 clinical trial has been ongoing in Costa Rica; a project sponsored by the National Cancer Institute, NCI. An estimated 20 percent of the women tested during the study were not administered the 3 doses of the vaccine.

Regardless of this, it was discovered by research scientists that all the women who were given a minimum of a single dose attained sufficient levels of antibodies potent against the HPV 16 and 18 strains in their blood for 4 years after initial treatment of HPV.

An expert with the NCI has reported that this discovery promises to invent a more easy method of administering the vaccine that will be less expensive, simple, and adopted worldwide.

Also, it was seen that giving women a shot or two of the HPV vaccine would in no small measure lower the cost of vaccination and make the logistics easy - a positive step relevant in developing countries where above 85 percent of cervical cancer happens which is directly related to deaths caused by cancer.

However, before altering the official schedule of vaccination, more studies need to be carried out and evaluated, including Gardasil efficacy which is the most common HPV vaccine. For hpv treatment in London, feel free to contact us.

It is advised that women complete any vaccination course they are receiving, including the HPV vaccine following their doctor's prescription.

Not all women are benefiting from this innovative medication

An interview conducted on a number of health professionals in private and public centres for cancer revealed that there were lapses in delivering the right care to patients classified as disadvantaged or minority.

According to reports, the limelight is on cervical cancer as it presents a chance to fight cancer in recent times. Based on this, there is the availability of screening, treatment and HPV vaccination service. Still, sadly women who are not insured and women of colour are not getting this treatment - a sign that the health system is having an issue which needs to be solved.

One solution recommended was to coordinate the activities of departments of health in state and federal levels to ensure those earning low income are reached with this medication - a move that will stretch the availability of this vaccine while reducing cost.

The huge challenge spotted in all this is how to bring programs that are funded separately to work together; a task that the public health system is still trying to achieve.

In the interim, should you be looking for HPV vaccine information, visit Gynae Clinic website https://www.gynae-clinic.co.uk/hpv-vaccine-london. Our doctors are ready and waiting to provide you with comprehensive details about this vaccine.